Proteomics Intl Labs Ltd has released a press release.
US PromarkerD patent expanded to all kidney disease
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Appendix 4C - corrected
- Appendix 4C - June 2017 Quarterly Report
- Proteomics wins major analytical services contract
- Response to ASX Query
- Clinical validation study confirms PromarkerD performance
Later from Proteomics International Laboratories
- PromarkerD predictive test results published - Diabetes Care
- Proteomics receives R&D tax incentive
- Appendix 4C - September 2017 Quarterly Report
- Proteomics partnered consortium to receive $2 million
- PromarkerD predictive diagnostic test to launch in Q1 2018
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories